16 April 2004
Lawrence sells South African business
Lawrence plc (Lawrence) is pleased to announce that it has sold the
trading business and certain of the assets of ECO Animal Health Southern
Africa (Pty) Ltd, its Pretoria based subsidiary, to the management team
headed by leading veterinarian Dr Peter Oberem, who has formed a new
black empowerment company, Afrivet Business Management (Pty) Ltd
(Afrivet).
ECO Animal Health Southern Africa (Pty) Ltd retains all its drug
registrations and has agreed to their exclusive use by Afrivet. Under a
new distribution and licence agreement Lawrence's UK based subsidiary,
ECO Animal Health Ltd (ECO), will receive a continuing payment based on
Afrivet's total sales, which should enhance the profitability of ECO.
As a result of this agreement, Afrivet has paid Lawrence approximately
£2 million to cover repayment of intercompany indebtedness and the
purchase of tangible assets from ECO Animal Health Southern Africa (Pty)
Ltd.
Peter Lawrence, Chairman of Lawrence, commented:
"South Africa is where ECO had its roots nearly 10 years ago and
continues to be an important market for us. This transaction is
particularly well timed as it benefits from the recent strength of the
rand against sterling and reduces future exchange exposure to the rand.
We are delighted that Peter Oberem has been able to achieve his ambition
of owning the business and we are confident that it will continue to
flourish under his motivating leadership. This is an excellent deal for
both companies and they will continue to benefit and work closely
together."
Contacts:
Peter Lawrence
Chairman, Lawrence plc
020 8336 2900
Anthony Spiro
Spiro Financial
020 8949 0428
Philip Davies
Charles Stanley & Co
020 7953 2000
Lawrence plc is a leader in the development, manufacture and
distribution of principally specialist chemical and pharmaceutical
products for the animal health and farming markets worldwide. Our
products for these growth markets incorporate natural ingredients to
promote well being and sustainability. We achieve our financial goals
through the careful and responsible application of science to generate
value for our shareholders.
Our corporate web site www.lawrenceplc.com includes our press releases
together with general information about the company and its
subsidiaries. Each subsidiary also has a web site, which gives further
information about that business and its products.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.